Atea Pharmaceuticals, Inc. (AVIR) earnings

  • Healthcare
  • NASDAQ
  • Market cap$316M

Next report

2027-03-04

In 104 daysQ4 FY2026Time not announced· Expected date
EPS consensus
-0.44
-0.69 – -0.412 analysts
Revenue consensus
$6.58M
Beat streak
3

Latest result

11 days ago

⁦+20.8%⁩EPS Beat

2026-11-09Q3 FY2026AMC
EPS
Reported / estimate-0.40 / -0.51
Revenue
— / $50.4M

Stock reaction

⁦-4.76%⁩

⁦-4.39⁩ pts vs SPY

Session ⁦2026-11-10⁩

Recent quarters

Latest 3 quarters

Revenue and stock reaction

Beat in 3 of 3 quarters with a measured stock reaction · beat then fell 2

Reported / estimate

  • Q3 FY2026 · 2026-11-09-4.76%
    EPS-0.40 / -0.51+20.8%
    Revenue— / $50.4M
  • Q2 FY2026 · 2026-08-12+0.20%
    EPS-0.41 / -0.56+26.1%
    Revenue— / $33.0M
  • Q1 FY2026 · 2026-05-12-16.91%
    EPS-0.57 / -0.60+5.0%
    Revenue— / $22.4M
  • Estimate recorded after the releaseNo estimate was saved before the results came out, so the surprise is measured against an estimate recorded after the release.

Reaction is the close of the reacting session versus the previous close. The gap to SPY is in percentage points.